Seegene Introduces Syndromic PCR Testing for HPV and STIs in Labs
Seegene Inc announced a syndromic polymerase chain reaction (PCR)-based testing approach for reproductive tract infections through the simultaneous…
The clinical utility of molecular residual disease testing in early-stage breast cancer
Molecular residual disease (MRD) testing using circulating tumor DNA assays shows promise in early-stage breast cancer by detecting…